Bicarbonate

Bicarbonate

SCHEMBL3415308

CCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCC.O=C(O)O.O=C(O)O.O=C(O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.67
PPARG P37231 7/20 0.67
PPARD Q03181 7/20 0.67
PPARA Q07869 7/20 0.67
HDAC11 Q96DB2 5/20 0.67
TSHR P16473 5/20 0.67
PTPN1 P18031 3/20 0.67
ALDH1A1 P00352 2/20 0.67
TLR2 O60603 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
FABP4 P15090 2/20 0.67
KMT2A Q03164 2/20 0.67
SLC22A6 Q4U2R8 1/20 0.67
SLC22A8 Q8TCC7 1/20 0.67
MEN1 O00255 1/20 0.67
ESR1 P03372 1/20 0.67
ALOX15 P16050 1/20 0.67
PDE4A P27815 1/20 0.67
PDE3A Q14432 1/20 0.67
HSD17B10 Q99714 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentadecane SCHEMBL8773457 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Bicarbonate SCHEMBL11317868 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Bicarbonate SCHEMBL5273883 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Bicarbonate SCHEMBL7775132 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Tetradecane SCHEMBL4614838 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Undecane SCHEMBL9545965 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Hexadecane SCHEMBL25216545 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Octane SCHEMBL20576382 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Undecane SCHEMBL20678412 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
Tridecane SCHEMBL165433 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11197874-B2 Use of an amphoteric chelating agent for preventing contact allergies PREVOR INTERNATIONAL (FR) 2021-12-14 US disclosed
US-20210275553-A1 USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN PREVOR INTERNATIONAL (FR) 2021-09-09 US disclosed
US-10953024-B2 Use of a cream that protects against the effects of aggressive chemical agents in contact with the skin PREVOR INTERNATIONAL (FR) 2021-03-23 US disclosed
EP-2874661-B1 USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN PREVOR INT (FR) 2018-08-08 EP disclosed
EP-2874604-B1 USE OF AN AMPHOTERIC CHELATING AGENT FOR PREVENTING CONTACT ALLERGIES PREVOR INT (FR) 2018-02-14 EP disclosed
US-9883991-B2 Alkyl sulfosuccinate mixtures, and use thereof COGNIS IP MANAGEMENT GMBH (DE) 2018-02-06 US disclosed
US-20150202217-A1 USE OF AN AMPHOTERIC CHELATING AGENT FOR PREVENTING CONTACT ALLERGIES PREVOR INTERNATIONAL (FR) 2015-07-23 US disclosed
US-20150190357-A1 USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN PREVOR INTERNATIONAL (FR) 2015-07-09 US disclosed
EP-2874604-A1 USE OF AN AMPHOTERIC CHELATING AGENT FOR PREVENTING CONTACT ALLERGIES PREVOR INTERNATIONAL (FR) 2015-05-27 EP disclosed
EP-2874661-A1 USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN PREVOR INTERNATIONAL (FR) 2015-05-27 EP disclosed
EP-2349989-B1 MIXTURES OF ALKYLSULFOSUCCINATES AND THEIR USE COGNIS IP MAN GMBH (DE) 2014-06-18 EP disclosed
WO-2014013195-A1 USE OF AN AMPHOTERIC CHELATING AGENT FOR PREVENTING CONTACT ALLERGIES PREVOR INTERNATIONAL (FR) 2014-01-23 WO disclosed
WO-2014013194-A1 USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN PREVOR INTERNATIONAL (FR) 2014-01-23 WO disclosed
US-20120128601-A1 Alkyl Sulfosuccinate Mixtures, And Use Thereof COGNIS IP MANAGEMENT GMBH (DE) 2012-05-24 US disclosed
EP-2179986-A1 Mixtures of alkylsulfosuccinates and their use Cognis IP Management GmbH (DE) 2010-04-28 EP disclosed
EP-2116221-A1 Cosmetic preparation containing hydrocarbons Cognis IP Management GmbH (DE) 2009-11-11 EP disclosed
EP-2111847-A1 Hydrocarbon mixtures and their use Cognis IP Management GmbH (DE) 2009-10-28 EP disclosed
EP-2014274-A1 Hydrocarbon compounds and their use Cognis IP Management GmbH (DE) 2009-01-14 EP disclosed
US-20070269525-A1 O/W Gel Compositions Comprising Wax COGNIS IP MANAGEMENT GMBH (DE) 2007-11-22 US disclosed
EP-1764080-A1 Cosmetic oil bodies Cognis IP Management GmbH (DE) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120128601-A1 Alkyl Sulfosuccinate Mixtures, And Use Thereof ASS1, STS, ARSA GPR84 1710/4885PPARG 1208/4885PPARD 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.